• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

    4/19/24 6:49:51 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care
    Get the next $MDAI alert in real time by email
    SC 13G/A 1 ea0204316-13ga1hir_spe.htm AMENDMENT NO. 1 TO SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    SCHEDULE 13G

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    (Amendment No. 1)*

     

     

     

    Spectral AI, Inc.

    (Name of Issuer)

     

    Common stock, par value $0.0001 per share (“Common Stock”)

    (Title of Class of Securities)

     

    84757T105

    (CUSIP Number)

     

    March 27, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐Rule 13d-1(b)

     

    ☒Rule 13d-1(c)

     

    ☐Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1 

    NAME OF REPORTING PERSONS

     

    Laurence E. Hirsch

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States citizen

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH
    REPORTING

    PERSON

    WITH

    5 

     

    SOLE VOTING POWER

     

    900,000 Shares(1)

    6

     

    SHARED VOTING POWER 

     

    0

    7

     

    SOLE DISPOSITIVE POWER

     

    900,000 Shares(1)

    8

     

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    900,000 Shares(1)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.15%

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    IN

     

    (1)Comprised of shares of Common Stock held by Highlander Partners, L.P., which shares were formerly held by Laurence E. Hirsch directly. Mr. Hirsch is the sole manager of Highlander Partners GP, LLC, the general partner of Highlander Partners, L.P.

     

    2

     

     

    1 

    NAME OF REPORTING PERSONS

     

    Highlander Partners, L.P.

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Texas

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5 

     

    SOLE VOTING POWER

     

    900,000 Shares

    6

     

    SHARED VOTING POWER

     

    0

    7

     

    SOLE DISPOSITIVE POWER

     

    900,000 Shares

    8

     

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    900,000 Shares

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.15%

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

     

    3

     

     

    1 

    NAME OF REPORTING PERSONS

     

    Highlander Partners GP, LLC

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒

     

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Texas

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH
    REPORTING

    PERSON

    WITH

    5 

     

    SOLE VOTING POWER

     

    0

    6

     

    SHARED VOTING POWER

     

    900,000 Shares(2)

    7

     

    SOLE DISPOSITIVE POWER

     

    0

    8

     

    SHARED DISPOSITIVE POWER

     

    900,000 Shares(2)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    900,000 Shares(2)

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.15%

    12

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

     

    (2)Comprised of shares of Common Stock held by Highlander Partners, L.P., of which Highlander Partners GP, LLC is the general partner.

     

    4

     

     

    Item 1(a). Name of Issuer

     

    Spectral AI, Inc.

     

    Item 1(b). Address of the Issuer’s Principal Executive Offices

     

    2515 McKinney Avenue, Suite 1000, Dallas, TX 75201

     

    Item 2(a). Names of Persons Filing

     

    Laurence E. Hirsch, Highlander Partners, L.P. and Highlander Partners GP, LLC

     

    Item 2(b). Address of the Principal Business Office, or if none, Residence:

     

    The address of the business office for Laurence E. Hirsch, Highlander Partners, L.P. and Highlander Partners GP, LLC is 300 Crescent Court, Suite 550, Dallas, TX 75201.

     

    Item 2(c). Citizenship

     

    Highlander Partners, L.P. and Highlander Partners GP, LLC - Texas

     

    Laurence E. Hirsch - United States citizen

     

    Item 2(d). Title of Class of Securities

     

    Common Stock, $0.0001 par value per share.

     

    Item 2(e). CUSIP Number

     

    84757T105

     

    Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

     

    ☐ (a) Broker or Dealer registered under Section 15 of the Exchange Act.
         
    ☐ (b) Bank as defined in Section 3(a)(b) or the Exchange Act.
         
    ☐ (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act.
         
    ☐ (d) Investment company registered under Section 8 of the Investment Company Act.
         
    ☐ (e) An Investment adviser in accordance with Rule 13d-1 (b)(1)(ii)(e).
         
    ☐ (f) An employee benefit plan or endowment fund in accordance with Rule 13d 1(b)(1)(ii)(f).
         
    ☐ (g) A Parent Holding Company or control person in accordance with Rule 13d 1(b)(1)(ii)(g).
         
    ☐ (h) A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act.
         
    ☐ (i) A Church Plan that is excluded from the definition of an investment company under Section 3 (c)(14) of the Investment Company Act.
         
    ☐ (j) Group, in accordance with Rule 13d-1 (b)(1)(ii)(j).

     

    Not applicable

     

    5

     

     

    Item 4. Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a)Amount beneficially owned: **
    LaurenceE. Hirsch – 900,000 shares
    HighlanderPartners, L.P. – 900,000 shares
    HighlanderPartners GP, LLC – 900,000 shares

     

    (b)Percent of class: **
    LaurenceE. Hirsch – 5.15%
    HighlanderPartners, L.P. – 5.15%
    HighlanderPartners GP, LLC – 5.15%

     

    (c)Number of shares as to which such person has: **

     

    (i)Sole power to vote or to direct the vote:
    LaurenceE. Hirsch – 900,000 shares
    HighlanderPartners, L.P. – 900,000 shares

     

    (ii)Shared power to vote or to direct the vote:
    HighlanderPartners GP, LLC – 900,000 shares

     

    (iii)Sole power to dispose or to direct the disposition of:
    LaurenceE. Hirsch – 900,000 shares
    HighlanderPartners, L.P. – 900,000 shares

     

    (iv)Shared power to dispose or to direct the disposition of:
    HighlanderPartners GP, LLC – 900,000 shares

     

    **See footnotes on cover pages which are incorporated by reference herein. 

     

    Item 5. Ownership of Five Percent or Less of a Class

     

    Not Applicable

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person

     

    Not Applicable

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

     

    Not Applicable

     

    Item 8. Identification and Classification of Members of the Group

     

    See Exhibit B

     

    Item 9. Notice of Dissolution of Group

     

    Not Applicable

     

    Item 10. Certification

     

    “By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a–11.”

     

    6

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    DATE: April 19, 2024

     

     

      LAURENCE E. HIRSCH
         
      /s/ Nicholas Thicksten
      Name:  Nicholas Thicksten
      Title: Attorney-In-Fact
         
      HIGHLANDER PARTNERS, L.P.
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary
         
      HIGHLANDER PARTNERS GP, LLC
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations

    (See 18 U.S.C. 1001)

     

    7

     

     

    EXHIBIT LIST

     

    Exhibit A.   Joint Filing Agreement.
    Exhibit B.   Item 8 Statement.
    Exhibit C.   Power of Attorney. (1)

     

    (1)Power of Attorney previously filed as Exhibit A to a Schedule 13G with regard to Spectral AI, Inc. filed with the Securities and Exchange Commission on November 3, 2023 by Laurence E. Hirsch.

     

    8

     

     

    Exhibit A

     

    JOINT FILING AGREEMENT

     

    The undersigned agree that this Schedule 13G, and all amendments thereto, relating to the Class A common stock of Spectral AI, Inc. shall be filed on behalf of the undersigned.

     

      LAURENCE E. HIRSCH
         
      /s/ Nicholas Thicksten
      Name:  Nicholas Thicksten
      Title: Attorney-In-Fact
         
      HIGHLANDER PARTNERS, L.P.
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary
         
      HIGHLANDER PARTNERS GP, LLC
         
      /s/ Chris McRorie
      Name: Chris McRorie
      Title: Vice President, General Counsel & Secretary

     

     

     

     

    Exhibit B

     

    Due to the relationships between them, the reporting persons hereunder may be deemed to constitute a “group” with one another for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $MDAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MDAI

    DatePrice TargetRatingAnalyst
    1/23/2024$4.00Buy
    BTIG Research
    More analyst ratings

    $MDAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/14/24 11:17:43 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Spectral AI with a new price target

      BTIG Research initiated coverage of Spectral AI with a rating of Buy and set a new price target of $4.00

      1/23/24 7:24:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

      DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Stanley Micek has been named the Company's Chief Operating Officer ("COO"). Micek's promotion reflects his role change from Interim COO of the Company since May, 2024 "Stan has demonstrated exceptional leadership, operational insight, and a deep understanding of our business during his time as interim COO," said Dr. J. Michael DiMaio, M.D., Chairman of the Company's Board of Directors. "His efforts leading our Research and Devel

      5/30/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

      DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced results from its 2025 Annual Meeting of Stockholders held earlier today. A total of 15,551,068 shares representing 60.8% of the Company's total shares outstanding were represented at the meeting, either in person or by proxy. Both of the proposals set forth by the Company were approved by its stockholders. The voting results are detailed below. Six directors were elected to serve on the Company's Board of Directors until the next Annual Me

      5/29/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Research Partner Using DeepView System Wins Best Research Project at the 2025 Education Awards

      DALLAS, May 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that its research partners, RCSI Skin Wounds and Trauma (SWaT) Research Center and RCSI Connolly Hospital, have been awarded Best Research Project at the 2025 Education Awards utilizing the DeepView System for their Diabetic Foot Ulcers (DFUs) project. The Education Awards recognize, encourage and celebrate excellence in third-level education across Ireland, including both state-funded and private institutions. The awards are par

      5/20/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    SEC Filings

    See more
    • Spectral AI Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      6/3/25 4:01:21 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      5/30/25 4:00:32 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      5/29/25 4:00:35 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Dimaio John Michael was granted 11,700 shares, increasing direct ownership by 0.47% to 2,503,608 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      6/10/25 4:01:14 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Director Mellish Martin C.B. was granted 5,000 shares, increasing direct ownership by 26% to 24,398 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      6/6/25 4:00:24 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Director Cotton Richard John was granted 9,699 shares, increasing direct ownership by 17% to 66,927 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/1/25 4:00:30 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care